• Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3

  • 2025/03/13
  • 再生時間： 56 分
  • ポッドキャスト

Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • There is a lot of stigma around psychedelics.

    Vicky is the CEO of EYWA, a biotech startup that produces molecules for mental health treatments. In this episode, we discussed the fundraising process for a startup working with psychedelics and the stigma surrounding the industry.

    Topics in this episode

    0:00 Intro
    1:07 Founding EYWA
    3:53 Advice for Startup Founders in LATAM
    8:51 What is Biosynthesis?
    12:34 What Molecules is EYWA Focusing On?
    13:35 How to Show Commercial Traction Before Regulatory Approval?
    15:03 The Psychedelics Ecosystem
    16:26 Scientific Data About Psychedelics
    23:51 What is EYWA's Business Model?
    25:49 How Does IP Shape an R&D Roadmap?
    27:56 Why Use AI and Bioinformatics?
    33:27 Regulatory Landscape for Psychedelics
    40:14 The Investors' Perception of Psychedelics
    44:17 EYWA's Most Recent Funding Round
    46:14 Building Relationships with Investors
    51:02 EYWA's Fundraising Plans
    51:37 Recording a TV Show with Tim and Adam Draper
    53:43 What's Next for EYWA

    Connect with Vicky on LinkedIn https://www.linkedin.com/in/victoria-costa-paz-a83499b2/
    Follow EYWA on LinkedIn https://www.linkedin.com/company/eywabio/posts/?feedView=all
    Follow EYWA on Instagram https://www.instagram.com/eywa.bio/

    Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/
    Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc
    Follow Science VC on Instagram https://www.instagram.com/science.vc

    Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC
    Subscribe to our Newsletter https://substack.com/@jporlov

    Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/
    続きを読む 一部表示

あらすじ・解説

There is a lot of stigma around psychedelics.

Vicky is the CEO of EYWA, a biotech startup that produces molecules for mental health treatments. In this episode, we discussed the fundraising process for a startup working with psychedelics and the stigma surrounding the industry.

Topics in this episode

0:00 Intro
1:07 Founding EYWA
3:53 Advice for Startup Founders in LATAM
8:51 What is Biosynthesis?
12:34 What Molecules is EYWA Focusing On?
13:35 How to Show Commercial Traction Before Regulatory Approval?
15:03 The Psychedelics Ecosystem
16:26 Scientific Data About Psychedelics
23:51 What is EYWA's Business Model?
25:49 How Does IP Shape an R&D Roadmap?
27:56 Why Use AI and Bioinformatics?
33:27 Regulatory Landscape for Psychedelics
40:14 The Investors' Perception of Psychedelics
44:17 EYWA's Most Recent Funding Round
46:14 Building Relationships with Investors
51:02 EYWA's Fundraising Plans
51:37 Recording a TV Show with Tim and Adam Draper
53:43 What's Next for EYWA

Connect with Vicky on LinkedIn https://www.linkedin.com/in/victoria-costa-paz-a83499b2/
Follow EYWA on LinkedIn https://www.linkedin.com/company/eywabio/posts/?feedView=all
Follow EYWA on Instagram https://www.instagram.com/eywa.bio/

Connect with JP Orlov on LinkedIn https://www.linkedin.com/in/jp-orlov/
Follow Science VC on LinkedIn https://www.linkedin.com/company/science-vc
Follow Science VC on Instagram https://www.instagram.com/science.vc

Subscribe to Science VC on YouTube https://www.youtube.com/@ScienceVC
Subscribe to our Newsletter https://substack.com/@jporlov

Learn how WeArePalta can help your deeptech company communicate its science and impact https://www.wearepalta.com/
続きを読む 一部表示

Raising Capital in a Controversial Industry | Psychedelics & Mental Health | Building Investor Relationships | Showing Traction Before Regulatory Approval | Imposter Syndrome in LATAM Startups with Victoria Costa Paz, CEO @ EYWA | Ep 3に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。